Merck beats first-quarter expectations on Keytruda, Gardasil strength

cafead

Administrator
Staff member
  • cafead   Apr 27, 2023 at 11:12: PM
via Drugmaker Merck & Co Inc (MRK.N) on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.

article source